In this article, we will discuss: 7 Best Hemp Stocks To Buy Now.
On April 30, Reuters reported that after the U.S. rescheduled loosened restrictions, firms developing cannabis-based drugs are planning for initial public offerings and private financing. Executives told Reuters that the regulatory adjustment lowers stigma and has the potential to attract mainstream investors. Melissa Sturgess, CEO of Ananda Pharma, said that the company is preparing to fund $10 million to $20 million, adding that “we have calls lined up already with a VC investor.” According to Reuters, the Justice Department has rescheduled FDA-approved cannabis treatments and state-regulated products, which will improve banking access and tax treatment.
Brett Schuman, co-chair of Goodwin, said, “Rescheduling will get the capital flowing again,” citing investor feedback. CEO of IGC Pharma Ram Mukunda said that limited banking access and timing uncertainties kept institutions away, despite interest. The company is considering a $50 million financing. Aras Azadian, CEO of Avicanna, noted that the earlier Schedule I status made U.S. research “quite difficult,” whereas rescheduling allows for market access and cooperation despite persisting federal-state regulatory gaps.
With that said, here are the 7 Best Hemp Stocks To Buy Now.
Methodology:
We used screeners to identify Hemp Stocks and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
7. GrowGeneration Corp. (NASDAQ:GRWG)
On March 24, 2026, GrowGeneration Corp. (NASDAQ:GRWG) reported that its Char Coir brand will release a next-generation propagation method, the Coco Coin Tray and Insert Tray. This will promote initial-stage plant development and cultivation performance. The firm marketed the technique as a “modern, mess-free” alternative to traditional soil or peat-based methods, targeted at both home gardeners and professional farmers, while developing proprietary services.
Founder Michael Leone said that the products provide “better starts, less transplant shock, and healthier plants,” resulting in an “ideal environment for early root development.” Darren Lampert, Chief Executive Officer, said that the launch is part of a plan to produce innovative products that improve grower outcomes while supporting profit expansion.
Separately, GrowGeneration Corp. said in its 2026 outlook that it expects net revenue of $162 million to $168 million. Its proprietary brands are expected to take up about 40% of Cultivation & Gardening sales, gross margins of 27% to 29%, and breakeven adjusted EBITDA.
GrowGeneration Corp. is involved in the development, marketing, retail, and distribution of hydroponic products and services. It operates in three segments: Cultivating and gardening, storage solutions, and corporate.
6. The Scotts Miracle-Gro Company (NYSE:SMG)
On April 29, Jefferies analyst Jonathan Matuszewski decreased his price target for The Scotts Miracle-Gro Company (NYSE:SMG) to $79 from $82. It maintained a Buy rating on the shares. The analyst added that it expects a “favorable set-up” because of new growth efforts and cost savings.
On April 29, The Scotts Miracle-Gro Company reported Q2 net sales of $1.46 billion, up 5% year on year. It also increased gross margin to 41.8%, up 280 basis points. The firm reported GAAP EPS of $4.46, increasing 18%, and adjusted EPS of $4.53, growing by 13%. Its adjusted EBITDA was $437.4 million, up by 9%.
CEO Jim Hagedorn said that the company “continued our growth trajectory.” CFO Mark Scheiwer said that the firm had “a strong second quarter,” and noted sales growth and profitability expansion.
The firm reaffirmed its 2026 outlook, which includes low single-digit US consumer sales growth and adjusted EPS of $4.15 to $4.35.
The Scotts Miracle-Gro Company makes, markets, and sells lawn and garden care products. It also gives indoor and hydroponic growing solutions.
5. Turning Point Brands, Inc. (NYSE:TPB)
On April 23, Alliance Global dropped its price target for Turning Point Brands, Inc. (NYSE:TPB) to $130 from $135. It maintained a Buy rating on the stock. The firm added that it cut forecasts ahead of the first quarter to reflect expected softness in legacy industries and expenditures in nicotine pouches weighing on profits.
Earlier, on March 3, Alliance Global analyst Aaron Grey boosted the target for Turning Point Brands, Inc. to $135 from $110 after Q4. It retained a Buy rating. The firm expected that 2026 would be a “healthy sales growth year,” although cautioning that higher trade spending adds uncertainty to net sales projections.
The firm also sees Turning Point Brands, Inc. as a possible “winner within the modern oral pouch category.”
Turning Point Brands, Inc.’ 2026 outlook expects Modern Oral gross revenue of $220 million to $240 million and net revenue of $180 million to $190 million. The first-quarter adjusted EBITDA is expected to be between $24 million and $27 million, including investments in sales, marketing, and trade promotions.
Turning Point Brands, Inc. manufactures, markets, and distributes branded consumer items, including alternative smoking accessories and consumables containing active substances. It functions through Zig-Zag Products, Stoker’s Products, and Creative Distribution Solutions segments.
4. SNDL Inc. (NASDAQ:SNDL)
On April 29, 2026, SNDL Inc. (NASDAQ:SNDL) reported its first-quarter 2026 results. It had net revenue of $195.9 million with a 4.4% year-over-year drop because of market issues in the liquor and cannabis areas. The company posted a gross profit of $52.8 million, down 6.8%, with a gross margin of 27.0%, down 0.7 percentage points. This was because of Cannabis Operations.
SNDL Inc. reported an operating loss of $9.1 million, up by $2.9 million from the previous year. It reflected the lack of prior value reductions and restructuring expenses. Cash flow stayed negative at $26.7 million, with free cash flow at negative $7.6 million, because of inventory buildups and income statement losses.
CEO Zach George said that the market downturn made the quarter “particularly challenging,” and noted persistent cost changes. The firm repurchased 4.5 million shares and concluded the quarter with $213.4 million in unrestricted cash and no debt, preparing for capital deployment.
SNDL Inc. is a licensed producer that makes limited cannabis in advanced indoor facilities. It operates in liquor retail, cannabis retail, cannabis operations, and investments segments.
3. High Tide Inc. (NASDAQ:HITI)
On April 20, 2026, High Tide Inc. (NASDAQ:HITI) announced that its Canna Cabana store in Caledonia, Ontario, will start adult-use cannabis sales, lifting its network to 221 sites countrywide and 97 in Ontario.
As per the company’s outlook, Canna Cabana handles 220 locations, and it is looking forward to adding 20-30 more in 2026. It has a long-term goal of topping 350 sites, besides looking into M&A prospects. It stated that its white-label portfolio has grown to 35 SKUs, accounting for 1.6% of retail sales, with plans to expand to about 20% over time.
High Tide Inc. said that Cabana Club membership in Canada surpassed 2.58 million, a 47% growth YoY, while global membership reached 6.65 million, with ELITE members exceeding 171,000 worldwide.
The company stated that its e-commerce unit contributed 2% of revenue and had recovered sequentially. Remexian pulled off $25 million in Q1 sales, up over 70% sequentially, with February revenue exceeding $12 million.
High Tide Inc. is a retail cannabis firm. It manufactures and distributes consumer accessories. It operates in three brick-and-mortar, e-commerce, and medical cannabis distribution segments.
2. Canopy Growth Corporation (NASDAQ:CGC)
On April 23, 2026, Canopy Growth Corporation (NASDAQ:CGC) announced a refresh of its Tweed cannabis brand. They are starting a nationwide summer promotion called “There’s a Tweed for That.” This promotion includes window bags, improved potency, and lower cost. The update gives consumers visibility into flower products while also addressing demand for accessible formats.
According to CEO Luc Mongeau, the revamp includes consumer and merchant feedback, “improved potency, sharpened pricing,” and a cleaner product presentation.
Earlier, on March 31, 2026, Canopy Growth Corporation debuted Deelish, a cannabis brand. This brand offers flower products with 27%-33% THC and pre-rolls with 26%-32% THC. Deelish rotates genetic offerings to supply cultivars throughout time, with a focus on daily consumers, it noted.
Mongeau said that the value market remains active, and Deelish is looking to provide “high-potency product at a price that respects how they shop.”
Canopy Growth Corporation produces, sells, and distributes cannabis and products derived from cannabinoids for both medical and recreational use. The company works in Canada Cannabis, International Markets Cannabis, Storz and Bickel, This Works, and Other areas.
1. Tilray Brands, Inc. (NASDAQ:TLRY)
On April 22, Bloomberg reported, citing an on-air discussion with CEO Irwin Simon, that Tilray Brands, Inc. (NASDAQ:TLRY) shares rose by around 10% after surging as much as 18% earlier, amid strong trading activity of more than 20 million shares. He said the move shows interest in a potential cannabis reclassification, stressing that it is important “for patients” and the larger business, not just the corporation. He noted that the corporation distributes cannabis in over 21 countries, producing more than $100 million globally and $200 million in Canada, as well as conducts research into medical applications such as cancer and epilepsy.
As per the CEO, Tilray Brands, Inc. does not currently sell cannabis in the United States, explaining that the company has instead grown into beer and beverages. He said that reclassification would help collaboration with the FDA, using current research for approvals addressing medical conditions. Entering the US market could happen “within six months” if licenses are granted, he said, calling the prospect “tremendous” given the firm’s infrastructure and global experience.
Tilray Brands, Inc. is a consumer packaged goods firm. It focuses on medical cannabis research and the cultivation, processing, and global distribution of cannabis products. It operates in the cannabis, distribution, beverage, and wellness segments.
READ NEXT: 20 Best Performing Stocks in 2025 and 12 Best Food Stocks to Buy in 2026.
